Dry Eye Syndrome Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Dry Eye Syndrome Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Dry Eye Syndrome Market Research
Report The latest report by IMARC, titled Dry
Eye Syndrome Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028 the global dry eye syndrome market
size reached US 4.5 Billion in 2022. Dry Eye
Syndrome is a common eye condition characterized
by inadequate lubrication and moisture on the
surface of the eye. It occurs when the tear
glands fail to produce enough tears or when the
tears evaporate too quickly, resulting in
dryness, irritation, and discomfort. It includes
symptoms such as a gritty or sandy sensation in
the eyes, redness, stinging or burning
sensations, excessive tearing, blurred vision,
and sensitivity to light. There are several
underlying causes of dry eye syndrome, including
aging, hormonal changes, certain medications,
medical conditions such as autoimmune disorders,
environmental factors, and lifestyle choices.
Some commonly used treatments include the use of
artificial tears or lubricating eye drops to
provide temporary relief. Request Free Sample
Report https//www.imarcgroup.com/dry-eye-syndrom
e-market/requestsample
4
Report Description and Highlights
Report Description

Global Dry Eye Syndrome Market Trends Lifestyle
changes and increased screen time is driving the
global market. Moreover, with the widespread use
of digital devices such as smartphones, tablets,
and computers, individuals are exposed to
prolonged periods of screen viewing, leading to
decreased blink rates and increased evaporation
of tears. This prolonged visual tasking and
reduced blinking contribute to the development of
dry eye symptoms, thereby fueling the demand for
DES treatments. Besides, with the global
population aging, the prevalence of DES is
expected to increase, leading to a greater demand
for effective treatments and management options.
Furthermore, various environmental factors, such
as pollution and dry climates, are augmenting the
DES market as exposure to environmental
pollutants, allergens, and irritants can trigger
or exacerbate dry eye symptoms, thus catalyzing
the market. Additionally, living in regions
with dry climates or spending time in
air-conditioned or heated environments can lead
to increased evaporation of tears and worsened
DES symptoms. Along with this, continual
advancements in diagnostic technologies and
techniques have improved the accuracy and
efficiency of DES diagnosis, allowing for earlier
detection and intervention. This is creating a
positive market outlook. Looking forward, the
market value is projected to reach US 6.3
Billion by 2028, expanding at a CAGR of 5.67
during 2023-2028. Looking forward, the market
value is projected to reach a strong growth
during the forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Disease Type Insights
Evaporative Dry Eye Syndrome Aqueous Dry
Eye Syndrome Drug Type Insights Anti-
inflammatory Drugs Lubricant Eye Drops
Autologous Serum Eye Drops
Product Insights Liquid Drops
Gel Liquid Wipes Eye Ointmen
t Others Distribution Channel Insights
Hospital Pharmacies

6
Report Description and Highlights
Report Description
Retail Pharmacies Online Pharm
acies Regional Insights North America
Europe Asia Pacific
Middle East and Africa Latin America

7
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Akorn Operating Company LLC Alimera Science Allerg
  an plc. Auven Therapeutics Bausch Lomb Incorpora
  ted GlaxoSmithKline plc Nicox S.A. Novartis AG Ots
  uka Holdings Co. Ltd
• Santen Pharmaceutical Co. Ltd.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/dry-eye-syndrome-market
  

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us